Glomerular diseases are major contributors to the global burden of end-stage kidney
disease. The clinical course and outcome of these disorders are extremely variable and …

Recent advances in glomerular biology have expanded our understanding of glomerular
diseases, leading to more precise therapeutic options. Since the discovery of the …

Glomerular diseases historically have been challenging disorders to comprehend and treat
for patients and physicians alike. Kidney biopsy is the gold standard of diagnosis, but the …

Immunoglobulin A (IgA) nephropathy is the most prevalent form of primary
glomerulonephritis that often leads to end-stage kidney failure, thereby representing a major …

IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-mediated
glomerular diseases with highly variable prognosis. Current guidelines recommend that …

Membranous nephropathy (MN) is the main cause of adult nephrotic syndrome (NS). The
pathogenesis of MN is complex and involves subepithelial immune complex deposition …

Glomerular diseases are often chronic or recurring and thus associated with a tremendous
physical, psychological, and economic burden. Their etiologies are often unknown, and their …

Membranous nephropathy (MN), an autoimmune glomerular disease, is one of the most
common causes of nephrotic syndrome in adults. In current clinical practice, the diagnosis is …

Over the past few years, considerable advances have been made in our understanding of
the molecular pathomechanisms of human membranous nephropathy, inspired by studies of …

Membranous nephropathy (MN) is relatively major cause of nephrotic syndrome in adults
which is recognized as an organ-specific autoimmune disease. The etiology of most cases is …